| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| REIMB | REIMB_KELA(317)_ICD10(L20) | Topical pimecrolimus and tacrolimus, Atopic dermatitis | 2185 | |
| REIMB | REIMB_KELA(317)_ICD10(L200) | Topical pimecrolimus and tacrolimus, Besnier's prurigo | 1323 | |
| REIMB | REIMB_KELA(134)_ICD10(L400) | General erythroderma, Psoriasis vulgaris | 218 | |
| REIMB | REIMB_KELA(134)_ICD10(L26) | General erythroderma, Exfoliative dermatitis | 105 | |
| REIMB | REIMB_KELA(395)_ICD10(L200) | Dupilumab, Besnier's prurigo | 102 | |
| REIMB | REIMB_KELA(395)_ICD10(L20) | Dupilumab, Atopic dermatitis | 98 | |
| REIMB | REIMB_KELA(134)_ICD9(NA) | General erythroderma, Name not found | 75 | |
| REIMB | REIMB_KELA(134)_ICD10(L20) | General erythroderma, Atopic dermatitis | 61 | |
| REIMB | REIMB_KELA(395)_ICD10(J33) | Dupilumab, Nasal polyp | 61 | |
| REIMB | REIMB_KELA(395)_ICD10(J45) | Dupilumab, Asthma | 52 | |
| REIMB | REIMB_KELA(134)_ICD8(NA) | General erythroderma, Name not found | 24 | |
| REIMB | REIMB_KELA(134)_ICD10(L200) | General erythroderma, Besnier's prurigo | 22 | |
| REIMB | REIMB_KELA(395)_ICD10(J330) | Dupilumab, Polyp of nasal cavity | 19 | |
| REIMB | REIMB_KELA(395)_ICD10(J451) | Dupilumab, Nonallergic asthma | 17 | |
| REIMB | REIMB_KELA(317)_ICD10(L209) | Topical pimecrolimus and tacrolimus, Atopic dermatitis, unspecified | 16 | |
| REIMB | REIMB_KELA(395)_ICD10(J450) | Dupilumab, Predominantly allergic asthma | 16 | |
| REIMB | REIMB_KELA(134)_ICD9(6961A) | General erythroderma, Psoriasis and similar disorders, Other psoriasis | 15 | |
| REIMB | REIMB_KELA(134)_ICD10(NA) | General erythroderma, Name not found | 10 | |
| REIMB | REIMB_KELA(395)_ICD10(J338) | Dupilumab, Other polyp of sinus | 7 | |
| REIMB | REIMB_KELA(134)_ICD10(L53) | General erythroderma, Other erythematous conditions | 6 | |
| REIMB | REIMB_KELA(395)_ICD10(J331) | Dupilumab, Polypoid sinus degeneration | 6 | |
| REIMB | REIMB_KELA(395)_ICD10(J459) | Dupilumab, Asthma, unspecified | 6 |